Jacaranda Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

Jacaranda General Information

Description

Operator of a preclinical-stage company intended to focus on restoring hearing loss. The company's platform specializes in research on genetic and noise-induced animal models of hearing loss and identified the mechanism that leads to noise-induced hair cell death, causing hearing loss, enabling researchers to identify small molecules that modulate overwhelming cellular stress response and restore homeostasis.

Contact Information

Website
www.jacaranda-bio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Corporate Drive, Bonneville Labs South
  • San Francisco, CA 94080
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 1 Corporate Drive, Bonneville Labs South
  • San Francisco, CA 94080
  • United States
+1 (415)

Jacaranda Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jacaranda Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Apr-2026 Completed Pre-Clinical Trials
5. Early Stage VC Completed Pre-Clinical Trials
4. Grant 01-Jan-2024 Completed Pre-Clinical Trials
3. Grant 01-Jan-2022 Completed Pre-Clinical Trials
2. Accelerator/Incubator 15-Sep-2016 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Jacaranda’s complete valuation and funding history, request access »

Jacaranda Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Jacaranda Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026198672-A1 Upr modulators to treat hearing loss Pending 18-Mar-2025
US-20250134871-A1 Upr modulators to treat hearing loss Pending 16-Dec-2021
WO-2023114451-A1 Upr modulators to treat hearing loss Inactive 16-Dec-2021 A61K31/44

Jacaranda Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
UCSF Innovation Ventures Venture Capital Minority
To view Jacaranda’s complete investors history, request access »

Ready to get started?

Request a free trial

Jacaranda FAQs

  • When was Jacaranda founded?

    Jacaranda was founded in 2014.

  • Where is Jacaranda headquartered?

    Jacaranda is headquartered in San Francisco, CA.

  • What industry is Jacaranda in?

    Jacaranda’s primary industry is Drug Discovery.

  • Is Jacaranda a private or public company?

    Jacaranda is a Private company.

  • What is Jacaranda’s current revenue?

    The current revenue for Jacaranda is .

  • Who are Jacaranda’s investors?

    National Institutes of Health and UCSF Innovation Ventures have invested in Jacaranda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process